Skip to main content
Premium Trial:

Request an Annual Quote

Centogene: Patrice Denèfle

Centogene has appointed Patrice Denèfle as CSO, effective Aug. 16. He will succeed Phil Lambert, who decided to leave the company, which he joined in late 2019. Denèfle comes to Centogene from 4P-Pharma, where he was CSO. Prior to that, he was general manager of the Roche Institute for Research and Translational Medicine, and he held senior roles at Sanofi Aventis and Ipsen. He also served as CSO at rare disease biotech firm Genethon. Denèfle holds a PhD in molecular biology and biotechnology from the Pasteur Institute.